Intra-Cellular Therapies (ITCI) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ITCI Stock Alerts $71.56 -1.56 (-2.13%) (As of 09:52 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAnalysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)markets.businessinsider.com - April 24 at 4:31 PMIntra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - April 24 at 4:31 PMIntra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Sharesglobenewswire.com - April 24 at 4:01 PMIntra-Cellular Therapies' (ITCI) "Overweight" Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - April 24 at 12:36 PM3 Biotech Stocks With Skyrocketing Potential: April 2024investorplace.com - April 24 at 11:36 AMIntra-Cellular Therapies (NASDAQ:ITCI) Given New $107.00 Price Target at Canaccord Genuity Groupamericanbankingnews.com - April 24 at 5:00 AMCanaccord Genuity Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $107.00marketbeat.com - April 23 at 11:22 AMIntra-Cellular Therapies (NASDAQ:ITCI) Given New $96.00 Price Target at Mizuhoamericanbankingnews.com - April 23 at 3:34 AMIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $90.00 by Analysts at Needham & Company LLCamericanbankingnews.com - April 23 at 3:34 AMIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $90.00marketbeat.com - April 22 at 1:31 PMIpsen, Skyhawk enter RNA targeting research collab in rare neurological diseasesmsn.com - April 22 at 8:09 AMIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Stock Holdings Increased by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 21 at 6:39 AMIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $77.00americanbankingnews.com - April 20 at 6:18 AMIntra-Cellular Therapies (NASDAQ:ITCI) Shares Gap Down to $76.69americanbankingnews.com - April 20 at 5:22 AMIntra-Cellular Therapies Incmoney.usnews.com - April 20 at 2:06 AMIntra-Cellular Therapies (NASDAQ:ITCI) Given New $91.00 Price Target at Bank of Americaamericanbankingnews.com - April 18 at 7:06 AMIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $90.00 by Analysts at TD Cowenamericanbankingnews.com - April 18 at 5:42 AMIntra-Cellular Therapies (NASDAQ:ITCI) Price Target Increased to $103.00 by Analysts at Robert W. Bairdamericanbankingnews.com - April 18 at 5:42 AMIntra-Cellular Therapies (NASDAQ:ITCI) Hits New 12-Month High at $81.41americanbankingnews.com - April 18 at 4:50 AMIntra-Cellular Therapies Prices Public Offering of Common Stockglobenewswire.com - April 17 at 8:46 PMThe Goldman Sachs Group Boosts Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $77.00marketbeat.com - April 17 at 4:27 PMIntra-Cellular Therapies (NASDAQ:ITCI) Stock Price Down 2.7%marketbeat.com - April 17 at 11:58 AMQuantum Private Wealth LLC Grows Stock Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)marketbeat.com - April 17 at 11:56 AMBiotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Pointinvestors.com - April 17 at 9:44 AMIntra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?finance.yahoo.com - April 17 at 9:38 AMBofA ups Intra-Cellular Therapies shares target, buoyed by positive Caplyta trial resultsinvesting.com - April 17 at 6:01 AMIntra-Cellular Therapies' (ITCI) Buy Rating Reaffirmed at Needham & Company LLCamericanbankingnews.com - April 17 at 3:50 AMIntra-Cellular Therapies: Hold Rating with Increased Price Target Amid Caplyta’s Clinical Successmarkets.businessinsider.com - April 16 at 7:39 PMHealthInvest Partners AB Invests $877,000 in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)marketbeat.com - April 16 at 6:50 PMIntra-Cellular Therapies Announces Proposed Public Offering of Common Stockglobenewswire.com - April 16 at 4:06 PMAnalysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Intra-Cellular Therapies (ITCI)markets.businessinsider.com - April 16 at 2:39 PMIntra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Studymsn.com - April 16 at 2:39 PMIntra-Cellular Launches 26% To Record High, Breaking Out After Depression Drug Scores Bigfinance.yahoo.com - April 16 at 2:39 PMIntra-Cellular: More Upside Possible Even After Positive MDD Treatment Dataseekingalpha.com - April 16 at 1:17 PMIntra-Cellular Therapies (NASDAQ:ITCI) Reaches New 52-Week High at $81.41marketbeat.com - April 16 at 11:02 AMIntra-Cellular Therapies Shares Rise on Lumateperone Study Resultsmarketwatch.com - April 16 at 9:38 AMIntra-Cellular Therapies Discloses Positive Study Results for Depression Treatmentmarketwatch.com - April 16 at 9:38 AMWhy Intra-Cellular Therapies Is Rising In Pre-market?markets.businessinsider.com - April 16 at 9:38 AMIntra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Resultsfinance.yahoo.com - April 16 at 9:38 AMIntra-Cellular Therapies (NASDAQ:ITCI) Receives Buy Rating from Needham & Company LLCmarketbeat.com - April 16 at 8:19 AMIntra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorderglobenewswire.com - April 16 at 7:00 AMmarketbeat.com - April 16 at 6:59 AMITCI Quantitative Stock Analysisnasdaq.com - April 15 at 9:35 AMPhocas Financial Corp. Buys New Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)marketbeat.com - April 15 at 8:29 AMIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - April 14 at 2:42 AMSG Americas Securities LLC Reduces Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)marketbeat.com - April 13 at 4:32 AMQ1 2024 EPS Estimates for Intra-Cellular Therapies, Inc. Lowered by Leerink Partnrs (NASDAQ:ITCI)marketbeat.com - April 12 at 6:08 AMIntra-Cellular Therapies (NASDAQ:ITCI) Earns Buy Rating from Needham & Company LLCmarketbeat.com - April 5 at 8:20 AM8 Analysts Assess Intra-Cellular Therapies: What You Need To Knowbenzinga.com - April 3 at 2:35 PMIntra-Cellular Therapies: A Strong Buy on Patent Defense and Promising Clinical Prospectsmarkets.businessinsider.com - April 3 at 9:35 AM Get Intra-Cellular Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for ITCI and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry ITCI Media Mentions By Week ITCI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ITCI News Sentiment▼0.570.44▲Average Medical News Sentiment ITCI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ITCI Articles This Week▼205▲ITCI Articles Average Week Get Intra-Cellular Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for ITCI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VKTX News JAZZ News CYTK News CERE News ELAN News IONS News ASND News APLS News LEGN News BPMC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ITCI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
